CrkL anticorps
-
- Antigène Voir toutes CrkL (CRKL) Anticorps
- CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CrkL est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human CRKL
- Isotype
- IgG
- Top Product
- Discover our top product CRKL Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.4 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))
- Autre désignation
- CRKL (CRKL Produits)
- Synonymes
- anticorps CRKL, anticorps wu:fa55g05, anticorps wu:fj60e01, anticorps zgc:63469, anticorps 1110025F07Rik, anticorps AA589403, anticorps AI325100, anticorps Crkol, anticorps CRK like proto-oncogene, adaptor protein, anticorps v-crk avian sarcoma virus CT10 oncogene homolog-like, anticorps CRKL, anticorps crkl, anticorps Crkl
- Sujet
- This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.
- Poids moléculaire
- 34 kDa
- NCBI Accession
- NP_005198
- UniProt
- P46109
- Pathways
- Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor
-